The microbicide tenofovir does not inhibit nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 763-765

  Wood, Billie Jo ^a   Rizzo Price, Patricia ^a   Holden, Jeff ^a   Hardick, Andrew ^a   Quinn, Thomas C ^a,b   Gaydos, Charlotte A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; TENOFOVIR;

ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CONCENTRATION RESPONSE; DILUTION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINALYSIS;

ADENINE; ANTI-INFECTIVE AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; URINE;

CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE;

EID: 38949180999     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01867-07     Document Type: Article

References (20)

1. Achilles, S. L., P. B. Shete, K. J. Whaley, T. R. Moench, and R. A. Cone. 2002. Microbicide efficacy and toxicity tests in mouse model for vaginal transmission of Chlamydia trachomatis. Sex. Transm. Dis. 29:655-664.
2. Balzarini, J., and L. Van Damme. 2007. Microbicide drug candidates to prevent HIV infection. Lancet 369:787-797.
3. Bentley, M. E., A. M. Fullem, E. E. Tolley, C. W. Kelly, N. Jogelkar, N. Srirak, L. Mwafulirwa, G. Khumalo-Sakutukwa, and D. D. Celentano. 2004. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am. J. Public Health 94:1159-1164.
4. Centers for Disease Control and Prevention. 2006. Sexually transmitted disease surveillance, 2005. U.S. Department of Health and Human Services, Atlanta, GA.
5. Crucitti, T., E. Van Dyck, A. Tehe, S. Abdellati, B. Vuylsteke, A. Bluve, and M. Laga. 2003. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex. Transm. Infect. 79:393-398.
6. D'Cruz, O. J., and F. M. Uckun. 2004. Clinical development of microbicides for the prevention of HIV infection. Curr. Pharm. Des. 10:315-336.
7. Dhawan, D., and K. H. Mayer. 2006. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J. Infect. Dis. 193:36-44.
8. Gaydos, C. A., and T. C. Quinn. 2005. Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice. Curr. Opin. Infect. Dis. 18:55-66.
9. Gaydos, C. A., M. Theodore, N. Dalesio, B. J. Wood, and T. C. Quinn. 2004. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 42:3041-3045.
10. Lederman, M. M., R. E. Offord, and O. Hartley. 2006. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat. Rev. Immunol. 6:371-382.
11. Madan, R. P., M. J. Keller, and B. C. Herold. 2006. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides. Curr. Opin. Infect. Dis. 19:49-54.
12. Mayer, K. H., L. A. Maslankowski, F. Gai, W. M. El-Sadr, J. Justman, A. Kwiecien, B. Mâsse, S. H. Eshleman, C. Hendrix, K. Morrow, J. Rooney, L. Soto-Torresi, et al. 2006. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS 20:543-551.
13. Phillips, D. M., and R. A. Maguire. 2002. The development of microbicides for clinical use to prevent sexually transmitted diseases. Curr. Infect. Dis. Rep. 4:135-140.
14. Rizzo-Price, P. A., P. Stamper, B. J. Wood, S. Reynolds, T. C. Quinn, and C. A. Gaydos. 2007. Can nucleic acid amplification tests be used to test for chlamydia and gonorrhea in microbicide trials? Int. J. STD AIDS 18:543-545.
15. Robbins, B. L., R. V. Srinivas, C. Kim, N. Bischofberger, and A. Fridland. 1998. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob. Agents Chemother. 42:612-617.
16. Shattock, R., and S. Solomon. 2004. Microbicides - aids to safer sex. Lancet 363:1002-1003.
17. Short, M. B., L. Mills, J. M. Majkowski, L. R. Stanberry, and S. L. Rosenthal. 2003. Topical microbicide use by adolescent girls. Sex. Transm. Dis. 30:854-858.
18. Stone, A. 2002. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1:977-985.
19. Van Rompay, K., M. McChesney, N. Aguirre, K. Schmidt, N. Bischofberger, and M. Marthas. 2001. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infections. J. Infect. Dis. 184:429-438.
20. Van Rompay, K. A., M. D. Miller, M. L. Marthas, N. A. Margot, P. J. Dailey, D. R. Canfield, et al. 2000. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. J. Virol. 74:1767-1774.